Skip to main content

Table 2 Estimated means and standard errors/95% confidence intervals for primary and secondary outcomes (n = 205)

From: Comparing enhanced versus standard Diabetes Prevention Program among indigenous adults in an urban setting: a randomized controlled trial

 

Baseline

Change from baseline to 6 months

Change from baseline to 12 months

Enhanced

Standard

Enhanced

Standard

Enhanced

Standard

Primary Outcomes

 BMI, kg/m2

37.8 ± 0.7

37.0 ± 0.7

− 0.3 (− 0.7,-0.02)

− 0.7 (− 1.0, − 0.4)

− 0.3 (− 0.7, 0.2)

− 0.5 (− 1.0, − 0.1)

 Percentage of participants with 5% weight loss

N/A

N/A

10.4 (4.4, 22.7)

20.7 (10.3, 37.1)

18.3 (9.0, 33.5)

23.7 (12.3, 40.7)

Secondary Outcomes

 SF-12

  Physical component

40.2 ± 1.3

41.5 ± 1.3

3.1 (1.0, 5.2)

3.0 (0.9, 5.1)

2.9 (0.7, 5.2)

2.2 (−0.1, 4.5)

  Mental component

48.0 ± 1.2

47.1 ± 1.2

1.7 (− 1.0, 4.3)

1.5 (− 1.1, 4.2)

0.3 (− 2.4, 3.0)

2.0 (− 0.7, 4.7)

Behavioral outcomes

 Diet

  Healthy

22.8 ± 0.5

22.6 ± 0.5

0.4 (− 0.7, 1.5)

− 0.6 (− 1.7, 0.5)

−0.4 (− 1.6, 0.9)

0.4 (− 0.9, 1.7)

  Unhealthy

35.4 ± 1.0*

37.9 ± 1.0*

− 2.51 (− 4.4, − 0.6)

−4.6 (− 6.5, − 2.8)

− 0.7 (− 2.9, 1.4)*

−4.6 (− 6.8, − 2.5)*

 Physical activity MET mins/week

1540.6 ± 150.3

1389.1 ± 149.7

− 23.5 (− 314.8, 267.8)

−94.3 (− 386.2, 197.6)

− 241.6 (− 591.9, 108.7)

144.6 (− 207.6, 496.8)

Clinical outcomes

 Waist circumference, in

47.2 ± 0.7

47.1 ± 0.7

− 2.1 (− 2.8, − 1.4)

− 2.7 (− 3.4, − 2)

− 1.8 (− 2.6, − 1)

−2.5 (− 3.2, − 1.7)

 SBP, mm Hg

125.3 ± 1.9

125.8 ± 1.9

−5.5 (− 8.7, − 2.2)

− 2.8 (− 5.9, 0.3)

− 4.1 (− 7.4, − 0.8)

−2.6 (− 5.8, 0.6)

 DBP, mm Hg

80.0 ± 1.3

78.8 ± 1.3

−4.4 (− 6.6, − 2.2)

−0.5 (− 2.7, 1.6)

− 1.2 (− 3.6, 1.2)

0.05 (−2.3, 2.4)

 Fasting glucose, mg/dL

101.0 ± 1.3

99.5 ± 1.3

1.9 (− 0.7, 4.4)

2.3 (− 0.2, 4.7)

5.0 (1.9, 8.0)

4.9 (1.9, 7.8)

 HDL, mg/dL

46.5 ± 1.6

46.9 ± 1.6

0.03 (− 1.9, 1.9)

1.0 (− 0.8, 2.8)

0.7 (− 1.5, 3)

0.7 (− 1.5, 3)

 LDL, mg/dL

102.9 ± 3.5

100.2 ± 3.5

1.6 (− 3.9, 7)

−0.5 (− 5.7, 4.7)

4.5 (− 2.9, 11.9)

2.8 (− 4.3, 9.9)

 Triglyceride, mg/dL

134.0 ± 8.7

146.9 ± 8.8

13.2 (− 4.2, 30.7)

−2.0 (− 19.0, 15.0)

21.7 (1.8, 41.7)

− 2.9 (− 22.5, 16.6)

Psychosocial outcomes

 CES-D

12.2 ± 1.1

13.9 ± 1.2

0.04 (− 2.2, 2.3)

−2.3 (− 4.6, − 0.1)

−0.1 (− 2.7, 2.6)

−1.2 (− 3.8, 1.5)

Empowerment

 Emotional empowerment

47.1 ± 1.1

46.2 ± 1.1

− 0.4 (− 2.7, 1.9)

0.2 (−2, 2.5)

0.9 (− 1.5, 3.2)

−0.3 (− 2.7, 2)

 Inner peace

27.7 ± 0.6

27.1 ± 0.7

−0.6 (− 2, 0.8)

0.2 (−1.1, 1.6)

0.4 (− 1, 1.8)

−0.2 (− 1.6, 1.2)

 Self-capacity

11.5 ± 0.4

11.3 ± 0.4

0.1 (− 0.6, 0.8)

−0.2 (− 0.8, 0.5)

0.2 (− 0.6, 0.9)

−0.3 (− 1.1, 0.4)

 Scenarios

57.1 ± 1.7

59.9 ± 1.8

−1.9 (− 5.1, 1.3)

−2.3 (− 5.6, 1)

−2.1 (− 5.3, 1.2)

0.2 (− 3.1, 3.5)

 Healing

33.5 ± 1.1

35.1 ± 1.1

− 1.4 (− 3.5, 0.6)

−1.6 (− 3.6, 0.5)

−1.9 (− 4, 0.1)

− 0.3 (− 2.4, 1.7)

 Connection

23.6 ± 0.8

24.9 ± 0.8

−0.5 (− 2.0, 1.0)

−0.7 (− 2.2, 0.8)

−0.1 (− 1.7, 1.4)

0.5 (−1.1, 2.1)

  1. Abbreviations: BMI body mass index; CES-D Center for Epidemiological Studies-Depression Scale; DBP diastolic blood pressure; HDL high-density; lipoprotein cholesterol; LDL low-density lipoprotein cholesterol; N/A not applied; SBP systolic blood pressure; SF-12 Short Form 12 Health Survey
  2. Boldface indicates between groups statistical significance (*P < 0.05)